The store will not work correctly when cookies are disabled.
7-(3-methoxyphenyl)-1-(pyrrolidin-1-yl)heptan-1-one
ID: ALA4518214
PubChem CID: 155541370
Max Phase: Preclinical
Molecular Formula: C18H27NO2
Molecular Weight: 289.42
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc(CCCCCCC(=O)N2CCCC2)c1
Standard InChI: InChI=1S/C18H27NO2/c1-21-17-11-8-10-16(15-17)9-4-2-3-5-12-18(20)19-13-6-7-14-19/h8,10-11,15H,2-7,9,12-14H2,1H3
Standard InChI Key: VXOXAQBFTNGRDN-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
9.5009 -3.5742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2086 -3.1656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9163 -3.5742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7932 -3.1656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0855 -3.5742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3778 -3.1656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6700 -3.5742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9623 -3.1656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2546 -3.5742 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9623 -2.3484 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5047 -3.2403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9578 -3.8476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3665 -4.5553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1658 -4.3853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9138 -4.3924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6206 -4.8010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3293 -4.3923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3267 -3.5709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6192 -3.1661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6202 -5.6181 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9123 -6.0264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
9 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 9 1 0
3 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 3 1 0
16 20 1 0
20 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 289.42 | Molecular Weight (Monoisotopic): 289.2042 | AlogP: 3.81 | #Rotatable Bonds: 8 |
Polar Surface Area: 29.54 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.72 | CX LogD: 3.72 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.68 | Np Likeness Score: -0.60 |
References
1. Zhou P, Xiang L, Zhao D, Ren J, Qiu Y, Li Y.. (2019) Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors., 10 (2): [PMID:30931090] [10.1039/C8MD00432C] |